AzTrials
AzTrials

StroketDCSNCT06891690

Use of tDCS Stimulation in Neurological and Gynaecological Conditions

A study testing tDSC stimulation in people with Stroke and Spinal Cord Diseases, run by Poznan University of Physical Education at 1 site in Poland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation. Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Stroke, Spinal Cord Diseases, Nerve Root Disorder
What is being tested?
tDSC stimulation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 sitePoland
Study dates
5 Feb 2025to 30 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • impairment of upper and lower limb function.
  • women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) with no treatment other than tDCS stimulation.

Who cannot join

  • no written consent to participate in the study.
  • Gynaecological patients
  • no written consent to participate in the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Małgorzata Wójcik, PhD PT contact

+48(95) 72 79 100

m.wojcik@awf-gorzow.edu.pl

Poland1 site, 1 recruiting
  • 1Department of Physiotherapy, Poznan University of Physical Education, Faculty of Sport Sciences in Gorzow Wlkp., 61-871 Poznan

    Poznan, 61-871

    Małgorzata Wójcik, PhD, m.wojcik@awf-gorzow.edu.pl

    Recruiting

Other trials in Poland

About this study

The aim of the study is to test the effect of tDCS stimulation on upper and lower limb function in neurological patients and to reduce pain in gynaecological patients. And the impact of tDCS stimulation on patients' quality of life. Standardised questionnaires will be used for pre- and post-stimulation evaluation.

Read the detailed description

Neurological patients:

  1. Main objective: The aim of the study is to see whether the use of tDCS stimulation incorporated into a rehabilitation programme in post-stroke patients and patients with spinal cord and nerve root dysfunction following neurosurgery and non-surgery will improve upper and lower limb function.
  2. Specific aim: To test whether the application of 1, 5 or 10 tDCS stimulations is sufficient to achieve improvements in upper and lower limb function, taking into account the dominant limb.
  3. Description of the study group The study will include women and men after stroke and spinal cord and nerve root dysfunction admitted for rehabilitation after surgery and not qualified for surgery, as well as healthy subjects. Study participants will be aged between 20-90 years. Post-stroke subjects with spinal cord and nerve root dysfunction will undergo individual rehabilitation using the PNF (Proprioceptive Neuromuscular Facilitation, Polish for proprioceptive neuromuscular facilitation) neurophysiological method performing upper and lower limb patterns. Rehabilitation will last between one and three months. Inclusion criterion: impairments of upper and lower limb function. Exclusion criterion: no written consent to participate in the study. Due to the assessment to be carried out, participants will be divided into groups:
  • women and men after stroke with and without tDCS stimulation 1, 5 or 10 treatments,
  • women and men with spinal cord and nerve root disorders after surgery with and without tDCS stimulation 1, 5 or 10 treatments,
  • women and men with spinal cord and nerve root disorders not qualified for surgery with tDCS stimulation 1.5 or 10 treatments and without,
  • healthy women and men undergoing all procedures including tDCS stimulation 1.5 or 10 without rehabilitation,
  • women and healthy men undergoing all procedures without tDCS stimulation and rehabilitation.
  1. Methods used in the research:

For the purpose of the study to be conducted, the subjects will have an assessment of:

  • body weight, body height, body composition using the Tanita BC-418 MA device before the start of the study, the subject stands barefoot on the electrodes in the shape of the foot, in his/her hand he/she also grasps the electrodes while being only in underwear and a measurement is taken, body composition indicators like BMI (Body Mass Index), muscle mass, fat mass, lean body mass and water content will be assessed, measured before the start of the study
  • biomechanical and viscoelastic properties of the skin using the MyotonPRO: during the measurement the subject will be in a standing position, the limbs of the subject will be exposed, the skin of both upper limbs (arm and forearm) and lower limbs (thigh and shank) will be assessed, on the anterior, posterior, lateral and medial sides, measurement before and after the test,
  • postural stability using the stabilometric platform Coordination, the subject will stand on the platform barefoot only in underwear, upper limbs placed along the torso, measurement will be done with eyes open and closed for a period of 30 seconds, measurement before and after the test,
  • upper limb reaction time using the Witty SEM Microgate, taking into account the dominant and non-dominant upper limb, the test person will stand in front of special sensors (semaphores) which will display letters and numbers in different colours, when ready the test person will have to find the small green letter 'a' 20 times as fast as possible. The total time of the test will be counted, the test person will be advised to be in comfortable sportswear (not restricting the movement of the upper limbs), the dominant and non-dominant limbs will be evaluated separately, measuring before and after the test,
  • assessment of the squeezing force of the right and left limb (hand dynamometer), test subjects will be asked to grasp the dynamometer and squeeze their hand with maximum force within 5 seconds.
  • lower limb reaction time using the Balance Toutor MedTouch platform, the test person will be in comfortable clothing, will be attached by a special harness to the device's extension arm to avoid a possible fall during the test, the test time for one person will last five minutes, the test person will walk on the device's treadmill at a speed of 3 m/s for two minutes, in order to adapt to the walking pace, in front of him/her on a monitor the test subject will see an image of the path in the forest on which he/she is walking in order to divert his/her attention, the device will then elicit a simulated fall reaction in forward, backward and sideways taking into account the test for the dominant and non-dominant lower limb, at the end of the test a record will be obtained for each test subject, recorded by the device in reaction time values, the test will be performed before and after the test,
  • tDCS Sooma DUO stimulation, the subject will be subjected to neuromodulation of the motor cortex, the treatment will be carried out in the sitting position, the subject will wear a cap with electrodes attached to the head, the treatment time will be 20-30 minutes, the maximum direct current will be 2 mA, the number of treatments will be 1, 5 or 10 (5 or 10 treatments daily from Monday to Friday) in the afternoon. Before and after the neuromodulation, tests will be carried out for the dominant and non-dominant hand: tapping on a tablet for 30 seconds, reflex flop test on a tablet (there will be glowing points that the subject must touch, the shorter the time to touch all the points, the better the score) and nine-hole peg test. In the course of neurostimulation, after 10 minutes the test person will perform mirror therapy, i.e. The subject will then perform mirror therapy, i.e. movements of the dominant hand controlled in the mirror image (wrist extension - 1 minute and 30 seconds pause, wrist flexion - 1 minute and 30 seconds pause, finger flexion and extension - 1 minute and 30 seconds pause, fist clenching and opening - 1 minute and 30 seconds pause, finger inversion and adduction - 1 minute and 30 seconds pause, middle finger tapping - 1 minute and 30 seconds pause, all fingers tapping - 1 minute).

Completion of questionnaires, the questionnaires used are:

  • Roland-Morris disability questionnaire, the questionnaire is completed by the examiner before and after examinations in patients with spinal cord and nerve root disorders,
  • Barthel scale, a questionnaire to be filled in by the examiner before and after examinations in stroke patients,
  • ASIA scale classification of spinal cord injuries, questionnaire to be filled in by the examiner before and after examinations in patients with spinal cord and nerve root disorders
  • Oswestry questionnaire assessment of lumbar spine pain intensity in various activities, questionnaire to be completed by the subject before and after the study,
  • Neck Disability Index questionnaire for cervical spine pain before and after the study,
  • Sexual Satisfaction Scale for Women (SSS - W - R15), assessment of satisfaction with current sexual life as well as communication with partner and sexual adjustment, questionnaire to be completed by the subject before and after the study,
  • male sex life evaluation questionnaire IIEF-5 is filled in by the subject before and after the study,
  • Katz scale is filled in by the subject before and after the study,
  • Lawton scale is filled in by the subject before and after the study,
  • WHOQOL BREF quality of life questionnaire to be completed by the subject before and after the study.

Planned procedures:

  1. recruitment of study participants,
  2. completion of questionnaires and scales,
  3. assessment of weight, height and body composition,
  4. ocean biomechanical and viscoelastic properties of the skin using MyotonPRO,
  5. assessment of postural stability using the stabilometric platform Coordination,
  6. upper limb reaction time using the Witty Sem Macro Gait device taking into account the dominant and non-dominant limb,
  7. middle finger tapping test,
  8. squeeze strength assessment,
  9. lower limb reaction time using the Balance Toutor MedTouch platform,
  10. tDCS stimulation.

Gynaecology patients:

  1. The aim of the study is to test the effect on pain reduction in women with gynaecological conditions such as endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome, who have had no treatment other than tDCS stimulation.
  2. Specific objective: application of stimulation in quantities; 3 treatments, 5 treatments and 10 treatments.
  3. Inclusion criterion: women with selected gynaecological conditions (endometriosis, painful menstruation, dyspareunia, polycystic ovary syndrome) not using any treatment other than tDCS stimulation.

Exclusion criterion: use of treatment other than tDCS stimulation, no written consent to participate in the study.

Patients who do not consent to tDCS stimulation will be placed in the control group.

Gynaecological patients will be asked to complete anonymously standardised questionnaires before and after stimulation, i.e. after 3 or 5 or 10.

Age of female respondents 18-70

For the purpose of the study to be conducted, the subjects will have an assessment of:

body weight, body height, body composition using the Tanita BC-418 MA device before the start of the study, the subject stands barefoot on the electrodes in the shape of the foot, in his/her hand he/she also grasps the electrodes while being only in underwear and a measurement is taken, body composition indicators like BMI (Body Mass Index), muscle mass, fat mass, lean body mass and water content will be assessed, measured before the start of the study biomechanical and viscoelastic properties of the skin using the MyotonPRO: during the measurement the subject will be in a standing position, the limbs of the subject will be exposed, the skin of both upper limbs (arm and forearm) and lower limbs (thigh and shank) will be assessed, on the anterior, posterior, lateral and medial sides, measurement before and after the test,

Standardised questionnaires:

  1. quality of life questionnaire WHOQOL-BREF.
  2. women's sexual satisfaction scale SSS-W-15 and Female Sexual Function Index
  3. Oswestry questionnaire
  4. Insomnia Severity Index.

Planned procedures:

  1. recruitment of study participants,
  2. completion of questionnaires and scales,
  3. assessment of weight, height and body composition,
  4. assessment of postural stability using the stabilometric platform Coordination,
  5. tDCS stimulation. Postural stability using the stabilometric platform Koordynacja, the subject will stand on the platform barefoot in underwear only, upper limbs placed along the torso, measurement will be taken with eyes open and closed for a period of 30 seconds, pre- and post-test measurement, In gynaecological patients of each stimulation is 20 minutes, current intensity to individual patient feeling, not exceeding 2 mA. Stimulation will be performed in a seated position.

Planned use of research results It is planned to present the obtained results in the form of publications in punctuated scientific journals and at Polish and foreign scientific conferences/congresses/symposia. Upon completion of the research experiment, the research participants will receive the results of the research along with their interpretation.

Being tested
tDSC stimulation
Keywords
tDCS stimulation, quality of life, pain
Medical subject headings
Stroke, Spinal Cord Diseases, Radiculopathy, Endometriosis, Dyspareunia, Dysmenorrhea, Polycystic Ovary Syndrome, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • tDSC stimulationOther

    Also called tDCS stimulation

    tDCA stimulation not exceeding 2 mA

Study groups in NCT06891690
Study groupRoleWhat they receive
tDCS stimulationExperimentalThe study group will have tDCS stimulation.
Receives: Other: tDSC stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. body height using Tanita BC-418 MA device

    height will be measured in centimeters

    Measured: through study completion, an average of 1 year

  2. biomechanical and viscoelastic properties of the skin using MyotonPRO

    The tissue voltage will be measured in Hertz (Hz)

    Measured: through study completion, an average of 1 year

  3. postural stability using the stabilometric platform Koordynacja

    the lower the frequency of anterior-posterior and medial-lateral swings, the better the stability

    Measured: through study completion, an average of 1 year

  4. upper limb reaction time using the Witty SEM Microgate device

    the shorter the time in seconds measured with a stopwatch, the better the result,

    Measured: through study completion, an average of 1 year

  5. assessment of right and left limb compression strength (hand dynamometer)

    test participants will be asked to grasp the dynamometer and clench their hands at maximum force for 5 seconds, the higher the value measured in kilograms, the greater the hand strength

    Measured: through study completion, an average of 1 year

  6. lower limb reaction time using the Balance Toutor MedTouch platform

    the shorter the time expressed in seconds, the better the function of the upper limb

    Measured: through study completion, an average of 1 year

  7. tDCS stimulation

    the subject will be subjected to neuromodulation of the motor cortex, the treatment will be carried out in sitting position, the subject will have a cap on his head with electrodes attached, the treatment time will be 20-30 minutes, the maximum value of direct current will be 2 mA, the number of treatments will be 1, 3, 5 or 10 ( 5 or 10 treatments performed daily from Monday to Friday) in the afternoon

    Measured: through study completion, an average of 1 year

  8. tapping test, reflex Flop test, Nine-Hole-Peg Test

    before and after the neuromodulation, the shorter the time expressed in seconds, the better the hand performance

    Measured: through study completion, an average of 1 year

  9. questionnaire Rolland-Morris

    maximum number of points 24, the higher the point value the higher the disability

    Measured: through study completion, an average of 1 year

  10. Barthel scale

    maximum score 100, the higher the score the more independent the person is

    Measured: through study completion, an average of 1 year

  11. ASIS scale

    maximum score 5, the higher the score the better the function

    Measured: through study completion, an average of 1 year

  12. Oswestry questionnaire

    maximum score 50, the higher the score the greater the disability due to lumbosacral pain

    Measured: through study completion, an average of 1 year

  13. Neck Disability Index questionnaire

    maximum score 50, the higher the score the greater the disability due to cervical pain

    Measured: through study completion, an average of 1 year

  14. Sexual Satisfaction Scale for Women questionnaire

    Maximum score 55, the lower the score the lower the sexual satisfaction

    Measured: through study completion, an average of 1 year

  15. Female Sexual Function Index questionnaire

    Maximum score 36, the lower the score the lower the sexual satisfaction

    Measured: through study completion, an average of 1 year

  16. IEF-5 male sex life assessment questionnaire

    A score of 21 or less may indicate symptoms of penile erectile dysfunction

    Measured: through study completion, an average of 1 year

  17. Katz scale (ADL - Activities of Daily Living)

    maximum score of 6 indicates preserved activities of daily living, lower scores indicate loss of function

    Measured: through study completion, an average of 1 year

  18. Lawton scale - IADL (basic activities of daily living)

    The maximum number of points is 27, the lower the score indicates a reduction in everyday functions

    Measured: through study completion, an average of 1 year

  19. WHOQOL-BREF questionnaire

    130 points (this is the maximum number of points that can be obtained) if it is satisfactory quality of life, 26 points (this is the minimum number of points that can be obtained) if there is no satisfactory quality of life

    Measured: through study completion, an average of 1 year

  20. Insomnia Severity Index

    maximum score of 28 indicating severity of insomnia symptoms, the lower the score the lower the insomnia symptoms

    Measured: through study completion, an average of 1 year

  21. body weight using Tanita BC-418 MA device

    body weight will be measured in kilograms

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2025
  2. Study start5 Feb 2025
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06891690
Sponsor's protocol ID
20/25
Acronym
tDCS
Status last verified
Sep 2026
First submitted
5 Feb 2025
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: When contacted by e-mail, when submitting a publication to a journal, editors often wish to send the raw data.

Questions about this trial

What is this clinical trial studying?

A study testing tDSC stimulation in people with Stroke and Spinal Cord Diseases, run by Poznan University of Physical Education at 1 site in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Małgorzata Wójcik, PhD PT (+48(95) 72 79 100, m.wojcik@awf-gorzow.edu.pl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

body height using Tanita BC-418 MA device (time frame: through study completion, an average of 1 year). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in